Commercial questions
Where is practical growth likely, which accounts are truly actionable, and what adoption barriers are material?
Healthcare intelligence
Healthcare analytics and decision-support tools for decisions that need to stand up.
Eye4Health brings 25+ years of healthcare and pharmaceutical experience to analytics, market access and NHS-facing decision-support and specialist expertise in open, public and commercially sourced healthcare datasets — helping commercial and NHS/NHS-adjacent customers answer difficult market, pathway, adoption and service planning questions with practical insight and usable tools.
Strategy and analytics partner. We do not provide clinical, prescribing, regulatory or compliance advice.
Founder-led and senior-led delivery for commercial and NHS-facing decision contexts.
Decision-support surface
Evidence to decision, with assumptions visible
Clients come to Eye4Health when the question is important and the data route is unclear.
01 · Evidence
Bring market, pathway, service, and adoption signals into one usable base.
02 · Context
Map variation and constraints so interpretation stays practical.
03 · Decision
Frame scenarios with explicit assumptions and confidence cues.
04 · Tool
Deliver a transparent output teams can apply, challenge, and update.
Delivery formats
Bespoke web tools, embedded Power BI and Tableau outputs, and decision-ready planning calculators.
How to engage
Bring one live decision, timeline, and current evidence base. We will return with a practical first-step approach.
Bridge
Commercial strategy and NHS-facing decisions are often the same evidence problem
The same pathway variation, adoption barriers, and service realities shape both commercial choices and NHS-facing planning.
Data advantage
The data advantage behind the decision
Important healthcare decisions often stall when teams start with a dataset, dashboard or model rather than the question itself. Eye4Health starts with the decision, then identifies the right mix of open, public, NHS-adjacent, commercial and client datasets.
The value is not just access to data. It is specialist judgement on which evidence can be trusted, connected, interpreted, and turned into a usable decision-support surface.
NHS-facing questions
How do pathway variation, service pressure, and local evidence quality change what is realistic to deliver?
Shared evidence spine
Method
Eye4Health operating model for decision-ready outputs
Four linked steps keep assumptions explicit and outputs tied to live decisions.
Step 1
Data
Assemble the right evidence base and expose quality limits early.
Step 2
Context
Interpret what pathways, adoption friction, and service realities imply.
Step 3
Interpretation
Frame assumptions and scenarios so trade-offs are explicit.
Step 4
Delivery
Deploy decision-support outputs teams can use under real pressure.
Showroom
All showroom demos →Working decision-support examples you can open today
These are live examples of how Eye4Health converts complex healthcare evidence into transparent tools people can actually use.
Each example demonstrates the translation of complex datasets into clear, usable decision-support surfaces.
Embedded analytics showcase
Bespoke web toolEmbedded analytics — illustrated with obesity in England
Eye4Health delivers interrogable analytics inside a governed, on-brand web experience — so medical, market access, and brand teams share one evidence story in workshops and planning. Below is a live illustration on open public-health data; commissioned work uses your sources, controls, and narrative.
Why this matters: evidence can be interrogated directly rather than reduced to static commentary.
Open demoPower BI pathway insight demo
Embedded Power BIOncology pathways — embedded Power BI (open NHS data)
Live showroom embed exploring oncology patient pathway dynamics from openly published NHS data — variation in diagnosis, referral, and management signals presented in Power BI inside Eye4Health’s governed, on-brand surface.
Why this matters: evidence can be interrogated directly rather than reduced to static commentary.
Open demoAATD prevalence planning demo
Planning calculatorAATD prevalence — population planning demo
Live prototype for alpha-1 antitrypsin deficiency (AATD): translate population size and cited prevalence scenarios into expected case counts — with optional confidence ranges, visible methodology, and assumptions you can defend in workshops.
Why this matters: evidence can be interrogated directly rather than reduced to static commentary.
Open demo
Decision questions
Questions we help teams answer
Commercial and NHS-adjacent choices often share the same evidence and pathway constraints.
Problem 1
Where is genuine growth likely, not just visible on market-size slides?
Combine open, public, commercial and client demand signals so plans reflect practical in-year opportunity.
Problem 2
Which accounts should be prioritised under access and field-capacity constraints?
Align account focus to local access friction, service reality and team capacity rather than theoretical potential.
Problem 3
What is slowing adoption: evidence, pathway design, or execution discipline?
Separate data absence, pathway variation and execution barriers so cross-functional teams intervene precisely.
Problem 4
Where does local pathway variation affect planning assumptions?
Surface differences in referral patterns, service pressure and local practice so planning choices are realistic.
Problem 5
Which datasets can answer this question well enough to support action?
Assess where evidence is strong enough, what should be combined, and which assumptions need explicit testing.
Problem 6
What level of service capacity is needed before adoption plans become credible?
Connect expected adoption patterns with operational constraints so delivery plans can stand up under scrutiny.
Model
Why senior judgement matters
Eye4Health is founder-led and senior-led, with 25+ years of healthcare and pharmaceutical experience applied directly to each engagement. Fewer handoffs, clearer ownership, and analysis grounded in commercial pressure and NHS operating realities.
Senior judgement matters because the hard part is rarely just analysis. It is knowing which datasets, assumptions and limits can support a decision.
Senior-led proof
- 25+ years
- Healthcare and pharmaceutical decision-support experience.
- Founder ownership
- Lead accountability from framing through delivery.
- Execution discipline
- Transparent assumptions and outputs built for scrutiny.
Case patterns
Explore case patterns →Anonymised patterns from decision-led work
Illustrative examples of how decision quality and execution discipline improve when evidence is made usable.
Outcome pattern
Access tracking rebuilt around decisions
- Context
- Large therapy launch with fragmented regional visibility.
- Intervention
- Replaced a broad KPI pack with an eight-indicator decision cadence tied to explicit ownership.
- Commercial outcome
- Weekly reporting effort fell and leadership reviews shifted from data arguments to action choices.
Outcome pattern
Forecast governance under competitive volatility
- Context
- Single-point forecast became difficult to defend after market events.
- Intervention
- Introduced scenario triggers, confidence bands, and evidence refresh checkpoints.
- Commercial outcome
- Commercial planning moved from reactive revision cycles to governed, trigger-based adjustments.
Product
Intelligence directory for UK healthcare market work
We built the healthcare data directory because the first question is often not "can you build a dashboard?" but "which data can answer this properly?"
It gives clients a shared starting point across open, public and commercially sourced healthcare datasets when market, pathway or service questions need a better answer.
Provided to Eye4Health clients as part of the way we work, with access to any third-party commercial datasets subject to the relevant licence or agreement.
Dataset
Monthly prescribing data by ICS
Coverage: England · update cycle: monthly · reliability: high.
Analyst note: suitable for directional account potential and post-launch trend analysis context.
Dataset
Referral-to-treatment pathway statistics
Coverage: national and regional views · reliability: medium.
Analyst note: strong for pathway pressure context; pair with local coding nuances before escalation decisions.
access planningdemand signalsevidence quality notes
Preview includes selected metadata and analyst commentary. Full access adds expanded source mapping and shortlist tools.
Early access release
Request access to view full source records, analyst annotations, and saved shortlist workflows.
Library
Browse the Insights Hub →Insights Hub
Practical notes on datasets, NHS context, access, and analytics craft — written for busy strategy and insights leaders.
Market access
Knowledge baseUnderstanding Marketing, Sales, and Market Access Challenges in the Pharmaceutical Industry
Enhance your data science skills by understanding UK pharma marketing, sales, and market access challenges at each stage of the product lifecycle.
18 March 2025 · 5 min read
Datasets
Knowledge baseUnlocking the Potential of the Quality and Outcomes Framework (QOF) Dataset for Pharmaceutical Market Access and Marketing
Explore how to leverage the Quality and Outcomes Framework (QOF) datasets for pharmaceutical market access and marketing. Discover practical tips and strategies.
10 March 2025 · 6 min read
Datasets
Knowledge baseA Guide to Public Health England’s Fingertips Datasets: Unlocking Insights
Learn how to leverage Public Health England's Fingertips datasets for pharmaceutical market access and marketing strategies. Explore insights, tips, and case studies.
3 March 2025 · 4 min read
Bring us the decision, not just the dataset.
If you are working through commercial or NHS-facing decisions around evidence, pathways, adoption, or service planning, we can help frame a practical next step.